|
04-24-2012 A New Lease on Life
|
04-12-2012 VIP: Bicyclic Peptides with Optimized Ring Size Inhibit Human Plasma Kallikrein and its Orthologs While Sparing Paralogous Proteases
|
03-27-2012 Focusing on Neglected Diseases
|
03-27-2012 Repurposing existing drugs: new hope against TB
|
03-22-2012 VIP: Characterization of Plasmodium Liver Stage Inhibition by Halofuginone
|
03-12-2012 VIP: Effects of Cyclic Lipodepsipeptide Structural Modulation on Stability, Antibacterial Activity, and Human Cell Toxicity
|
03-02-2012 ChemistryOpen: First Issue!
|
02-10-2012 VIP: Discovery of [(2R,5R)-5-{[(5-Fluoropyridin-2-yl)oxy]methyl}-2-methylpiperidin-1-yl][5-methyl-2-(pyrimidin-2-yl)phenyl]methanone (MK-6096): A Dual Orexin Receptor Antagonist with Potent Sleep-Promoting Properties
|
02-04-2012 VIP: Fluorogenic Peptide-Based Substrates for Monitoring Thrombin Activity
|
01-24-2012 VIP: Engineering and Functionalization of the Disulfide-Constrained Miniprotein Min-23 as a Scaffold for Diagnostic Applications
|
12-23-2011 VIP: Discovery of Novel Stem Cell Mobilizers That Target the CXCR4 Receptor
|
12-08-2011 Roth Describes Changing Pharma Landscape as Patent Cliff Looms
|
11-21-2011 VIP: Aspirin Analogues as Dual Cyclooxygenase-2/5-Lipoxygenase Inhibitors: Synthesis, Nitric Oxide Release, Molecular Modeling, and Biological Evaluation as Anti-Inflammatory Agents
|
11-10-2011 Philip S. Portoghese, Editor-in-Chief of J. Med. Chem., Steps Down at the End of 2011
|
11-04-2011 VIP: Huprine Derivatives as Sub-Nanomolar Human Acetylcholinesterase Inhibitors: From Rational Design to Validation by X-ray Crystallography
|
10-18-2011 VIP: Development of Isoxazoline-Containing Peptidomimetics as Dual αvβ3 and α5β1 Integrin Ligands
|
10-13-2011 2011 CNRS Bronze Medal Awarded to Karine Alvarez
|
10-13-2011 Rainer Metternich to Lead the Small Molecules Research Program at Roche
|
10-13-2011 VIP: Insights into Matriptase-2 Substrate Binding and Inhibition Mechanisms by Analyzing Active-Site-Mutated Variants
|
10-13-2011 VIP: Structure-Based Discovery of Allosteric Modulators of Two Related Class B G-Protein-Coupled Receptors
|
10-13-2011 VIP: Understanding of Molecular Substructures that Contribute to hERG K+ Channel Blockade: Synthesis and Biological Evaluation of E-4031 Analogues
|
10-11-2011 VIP: From a Library of MAG Antagonists to Nanomolar CD22 Ligands
|
10-11-2011 VIP: From Catalysts to Bioactive Organometallics: Do Grubbs Catalysts Trigger Biological Effects?
|
10-11-2011 VIP: Rofecoxib Analogues Possessing a Nitric Oxide Donor Sulfohydroxamic Acid (SO2NHOH) Cyclooxygenase-2 Pharmacophore: Synthesis, Molecular Modeling, and Biological Evaluation as Anti-inflammatory Agents
|
10-11-2011 VIP: Urolithin as a Converging Scaffold Linking Ellagic Acid and Coumarin Analogues: Design of Novel Potent Protein Kinase CK2 Inhibitors
|
10-08-2011 VIP: A Comparison of Linear and Cyclic Peptoid Oligomers as Potent Antimicrobial Agents
|
10-08-2011 VIP: Exhaustive Fluorine Scanning toward Potent p53–Mdm2 Antagonists
|
10-08-2011 VIP: Identification and Characterization of Inhibitors of the Aminoglycoside Resistance Acetyltransferase Eis from Mycobacterium tuberculosis
|
10-05-2011 2011 Nobel Prize in Physiology or Medicine goes to Beutler, Hoffmann, Steinman
|
09-14-2011 VIP: Discovery of a Pharmacologically Active Antagonist of the Two-Pore-Domain Potassium Channel K2P9.1 (TASK-3)
|
08-29-2011 VIP: Structure–Activity Relationship for the First-in-Class Clinical Steroid Sulfatase Inhibitor Irosustat (STX64, BN83495)
|
07-28-2011 VIP: (S)- and (R)-Fluoxetine as Native Markers in MS Binding Assays Addressing the Serotonin Transporter
|
07-14-2011 VIP: Synthesis and Structure–Activity Relationships of a Class of Sodium Iodide Symporter Function Inhibitors
|
07-05-2011 VIP: Cell-Free HIV-1 Virucidal Action by Modified Peptide Triazole Inhibitors of Env gp120
|
06-16-2011 VIP: Polyphosphates and Pyrophosphates of Pentopyranoses and Pentofuranoses as Allosteric Effectors of Human Hemoglobin: Synthesis, Molecular Recognition, and Oxygen Release
|
05-13-2011 VIP: Identification of Benzopyran-4-one Derivatives (Isoflavones) as Positive Modulators of GABAA Receptors
|
04-22-2011 World Malaria Day: April 25th
|
04-19-2011 VIP: Evidence for the Existence of a Specific G-Protein-Coupled Receptor Activated by Guanosine
|
04-19-2011 VIP: Inhibition of Histone Demethylases by 4-Carboxy-2,2'-Bipyridyl Compounds
|
04-07-2011 VIP: Mechanism of Cytotoxicity and Cellular Uptake of Lipophilic Inert Dinuclear Polypyridylruthenium(II) Complexes
|
03-29-2011 ChemMedChem 04/2011: Women in Chemistry (IYC 2011)
|
03-23-2011 World TB Day 2011: March 24
|
03-17-2011 VIP: Hybrid Lipoic Acid Derivatives to Attack Prion Disease on Multiple Fronts
|
03-16-2011 VIP: Biphenyl Sulfonylamino Methyl Bisphosphonic Acids as Inhibitors of Matrix Metalloproteinases and Bone Resorption
|
03-11-2011 VIP: Sulfonylthiadiazoles with an Unusual Binding Mode as Partial Dual Peroxisome Proliferator-Activated Receptor (PPAR) γ/δ Agonists with High Potency and in vivo Efficacy
|
03-10-2011 VIP: Discovery and Biological Activity of 6BrCaQ as an Inhibitor of the Hsp90 Protein Folding Machinery
|
02-08-2011 ChemMedChem at the 10th Winter Conference on Medicinal and Bioorganic Chemistry, January 23–27, 2011, Steamboat Springs, Colorado (USA)
|
02-02-2011 ChemMedChem 02/2011: Rare and Neglected Diseases
|
02-02-2011 VIP: BZM055, an Iodinated Radiotracer Candidate for PET and SPECT Imaging of Myelin and FTY720 Brain Distribution
|
01-25-2011 VIP: Pyrido[1,2-a]benzimidazole-Based Agents Active Against TB, MDR-TB, and XDR-TB
|
01-19-2011 VIP: A Versatile and Practical Synthesis toward the Development of Novel HIV-1 Integrase Inhibitors
|
01-16-2011 VIP: Revealing Atropisomer Axial Chirality in Drug Discovery
|
01-04-2011 ChemMedChem Gets a New Editor
|
11-11-2010 VIP: 1-Cyclohexyl-4-(4-arylcyclohexyl)piperazines: Mixed σ and Δ8–Δ7 Sterol Isomerase Ligands with Antiproliferative and P-Glycoprotein Inhibitory Activity
|
11-08-2010 VIP: Characterization of C-Alkyl Amidines as Bioavailable Covalent Reversible Inhibitors of Human DDAH-1
|
10-28-2010 ChemMedChem 11/2010: 25 Years of Anti-HIV Research
|
10-26-2010 VIP: Asborin Inhibits Aldo/Keto Reductase 1A1
|
10-26-2010 VIP: Chemotherapeutic Evaluation of a Synthetic Tubulysin Analogue–Dendrimer Conjugate in C26 Tumor Bearing Mice
|
10-26-2010 VIP: Synthesis, Cytotoxicity, and COMPARE Analysis of Ferrocene and [3]Ferrocenophane Tetrasubstituted Olefin Derivatives against Human Cancer Cells
|
10-06-2010 VIP: Molecular Assembly of Multifunctional 99mTc Radiopharmaceuticals Using "Clickable" Amino Acid Derivatives
|
09-29-2010 VIP: Target Profiling of a Small Library of Phosphodiesterase 5 (PDE5) Inhibitors using Chemical Proteomics
|
09-22-2010 Wiley and ChemMedChem at the International Symposium on Medicinal Chemistry 2010 in Brussels
|
09-17-2010 VIP: Probing Multidrug-Resistance and Protein–Ligand Interactions with Oxatricyclic Designed Ligands in HIV-1 Protease Inhibitors
|
09-02-2010 VIP: Synthesis and Evaluation of Bombesin Analogues Conjugated to Two Different Triazolyl-Derived Chelators for 99mTc Labeling
|
08-30-2010 ChemMedChem 09/2010: Fighting Cancer
|
08-19-2010 VIP: The Active Core in a Triazole Peptide Dual-Site Antagonist of HIV-1 gp120
|
08-09-2010 ChemMedChem Author Guidelines Updated!
|
08-03-2010 ChemMedChem's Success Recognized by Thompson Reuters: Editorial Team Interview Appears in ScienceWatch
|
08-03-2010 VIP: High-Resolution Crystal Structure of a Lasso Peptide
|
08-03-2010 VIP: Novel 3-Carboxy- and 3-Phosphonopyrazoline Amino Acids as Potent and Selective NMDA Receptor Antagonists: Design, Synthesis, and Pharmacological Characterization
|
06-27-2010 VIP: Synthesis and Biological Characterization of Amidopropenyl Hydroxamates as HDAC Inhibitors
|
06-17-2010 New 2009 Impact Factor: 3.232
|
06-17-2010 VIP: Proteins as Possible Targets for Cytotoxic trans-Platinum(II) Complexes with Aliphatic Amine Ligands: Further Exceptions to the DNA Paradigm
|
06-15-2010 VIP: Discovery of a Class of Diketopiperazines as Antiprion Compounds
|
06-15-2010 VIP: Homology Modelling of the GABA Transporter and Analysis of Tiagabine Binding
|
06-15-2010 VIP: HTS and Rational Drug Design to Generate a Class of 5-HT2C-Selective Ligands for Possible Use in Schizophrenia
|
06-15-2010 VIP: Inhibition Studies of Mycobacterium tuberculosis Salicylate Synthase (MbtI)
|
06-15-2010 VIP: Jostling for Position: Optimizing Linker Location in the Design of Estrogen Receptor-Targeting PROTACs
|
05-22-2010 VIP: The Role of Fluorine Atoms in a Fluorinated Prostaglandin Agonist
|
05-22-2010 VIP: Thiazolopyrimidine Inhibitors of 2-Methylerythritol 2,4-Cyclodiphosphate Synthase (IspF) from Mycobacterium tuberculosis and Plasmodium falciparum
|
04-23-2010 Arun K. Ghosh Awarded the 2010 IUPAC-Richter Prize
|
04-12-2010 VIP: Design, Synthesis, and Preliminary Biological Evaluation of Pyrrolo[3,4-c]quinoline-1-one and Oxoisoindoline Derivatives as Aggrecanase Inhibitors
|
03-22-2010 VIP: Azides Derived from Colchicine and Their Use in Library Synthesis: a Practical Entry to New Bioactive Derivatives of an Old Natural Drug
|
03-18-2010 VIP: A Highly Potent and Selective Caspase 1 Inhibitor that Utilizes a Key 3-Cyanopropanoic Acid Moiety
|
03-18-2010 VIP: Highly Potent Modulation of GABAA Receptors by Valerenic Acid Derivatives
|
03-18-2010 VIP: Molecular Editing of Kinase-Targeting Resorcylic Acid Lactones (RAL): Fluoroenone RAL
|
03-09-2010 VIP: Anticancer Activity of Vitamin E-Derived Compounds in Murine C6 Glioma Cells
|
01-23-2010 VIP: Lectin-Based Drug Design: Combined Strategy to Identify Lead Compounds using STD NMR Spectroscopy, Solid-Phase Assays, and Cell Binding for a Plant Toxin Model
|
01-15-2010 VIP: Pro-oxidant Properties of AZT and other Thymidine Analogues in Macrophages: Implication of the Azido Moiety in Oxidative Stress
|
01-15-2010 VIP: Selective Pharmacophore Models of Dopamine D1 and D2 Full Agonists Based on Extended Pharmacophore Features
|
01-15-2010 VIP: Upgrading a Natural Product: Inhibition of Human β-Tryptase by Cyclotheonamide Analogues
|
01-12-2010 New Editorial Board and International Advisory Board Members
|
01-12-2010 VIP: Chelator Fragment Libraries for Targeting Metalloproteinases
|
11-19-2009 Thalidomide: a Revival
|
11-13-2009 VIP: Comparison of Structure- and Ligand-Based Virtual Screening Protocols Considering Hit List Complementarity and Enrichment Factors
|
11-13-2009 VIP: Evaluation of Novel Epothilone Analogues by means of a Common Pharmacophore and a QSAR Pseudoreceptor Model for Taxanes and Epothilones
|
11-13-2009 VIP: How to Replace the Residual Solvation Shell of Polar Active Site Residues to Achieve Nanomolar Inhibition of tRNA-Guanine Transglycosylase
|
11-05-2009 VIP: Thermodynamic Optimisation in Drug Discovery: A Case Study using Carbonic Anhydrase Inhibitors
|
11-04-2009 Steven Ley Awarded the 2009 Heinrich Wieland Prize
|
10-27-2009 ChemMedChem 11/2009: Computer Power!
|
10-22-2009 VIP: Interaction of Artemisinins with Oxyhemoglobin Hb–FeII, Hb–FeII, CarboxyHb–FeII, Heme–FeII, and Carboxyheme FeII: Significance for Mode of Action and Implications for Therapy of Cerebral Malaria
|
09-29-2009 ChemMedChem 10/2009: Tackling Tumors!
|
08-31-2009 ChemMedChem 09/2009: Shockingly Hot!
|
06-25-2009 Going for Impact!
|
10-23-2008 Giordano Giacomello Medal to G. Tarzia
|
08-28-2008 Ley, Seeberger, and Kubinyi Awarded
|
10-08-2007 Nobel Prize in Physiology or Medicine 2007 to Capecchi, Evans, and Smithies
|
06-15-2007 ChemMedChem in Web of Science
|
12-01-2006 First Volume of ChemMedChem Completed
|
10-02-2006 RNA Interference Earns Fire, Mello Nobel Prize
|
07-11-2006 ChemMedChem now accepted in MEDLINE
|
10-04-2005 Nobel Prize in Medicine/Physiology to Marshall/Warren |
|